scholarly journals Phase Ia/Ib study of taselisib in Japanese patients with solid tumors or hormone receptor positive breast cancer

2016 ◽  
Vol 27 ◽  
pp. vii7
Author(s):  
Akihiko Shimomura ◽  
Kan Yonemori ◽  
Chikako Shimizu ◽  
Kenji Nakano ◽  
Junichi Tomomatsu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Solid Tumors ◽  
Hormone Receptor ◽  
Japanese Patients ◽  
Hormone Receptor Positive ◽  
Positive Breast Cancer

scholarly journals Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer

2018 ◽  
Vol 109 (5) ◽  
pp. 1592-1601 ◽  
Author(s):  
Kenji Tamura ◽  
Makoto Kodaira ◽  
Chikako Shimizu ◽  
Kan Yonemori ◽  
Mayu Yunokawa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Solid Tumors ◽  
Hormone Receptor ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Breast ◽  
Advanced Solid Tumors ◽  
Hormone Receptor Positive

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases

2019 ◽  
Vol 144 (3) ◽  
pp. 583-589 ◽  
Author(s):  
Nicholas B. Figura ◽  
Thrisha K. Potluri ◽  
Homan Mohammadi ◽  
Daniel E. Oliver ◽  
John A. Arrington ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Hormone Receptor ◽  
Stereotactic Radiation ◽  
Hormone Receptor Positive ◽  
Breast Cancer Brain Metastases ◽  
Positive Breast Cancer

Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients

2017 ◽  
Vol 17 (5) ◽  
pp. 356-366 ◽  
Author(s):  
Xiaoxian Li ◽  
Jing Yang ◽  
Uma Krishnamurti ◽  
Lei Huo ◽  
Kevin C. Ward ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hormone Receptor ◽  
Female Patients ◽  
Hormone Receptor Positive ◽  
Worse Prognosis ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document